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ABSTRACT
Objective The treatment of infective endocarditis 
(IE) has become more complex with the current 
myriad healthcare- associated factors and the regional 
differences in causative organisms. We aimed to 
investigate the overall trends, microbiological features, 
and outcomes of IE in South Korea.
Methods A 12- year retrospective cohort study was 
performed. Poisson regression was used to estimate 
the time trends of IE incidence and mortality rate. Risk 
factors for in- hospital mortality were identified with 
multivariable logistic regression, and model comparison 
was performed to evaluate the predictive performance 
of notable risk factors. Kaplan- Meier survival analysis 
and Cox regression were performed to assess long- term 
prognosis.
Results We included 419 patients with IE, the incidence 
of which showed an increasing trend (relative risk 1.06, 
p=0.005), whereas mortality demonstrated a decreasing 
trend (incidence rate ratio 0.93, p=0.020). The in- 
hospital mortality rate was 14.6%. On multivariable 
logistic regression analysis, aortic valve endocarditis 
(OR 3.18, p=0.001), IE caused by Staphylococcus 
aureus (OR 2.32, p=0.026), neurological complications 
(OR 1.98, p=0.031), high Sequential Organ Failure 
Assessment score (OR 1.22, p=0.023) and high Charlson 
Comorbidity Index (OR 1.11, p=0.019) were predictors 
of in- hospital mortality. Surgical intervention for IE was a 
protective factor against in- hospital mortality (OR 0.25, 
p<0.001) and was associated with improved long- 
term prognosis compared with medical treatment only 
(p<0.001).
Conclusions The incidence of IE is increasing in South 
Korea. Although the mortality rate has slightly decreased, 
it remains high. Surgery has a protective effect with 
respect to both in- hospital mortality and long- term 
prognosis in patients with IE.
INTRODUCTION
Despite advances in diagnostics and therapeutics, 
infective endocarditis (IE) remains associated with 
high morbidity and mortality.1 The epidemiology 
of IE varies and depends on multiple hosts and 
microbiological factors.2 3 Moreover, IE treatment 
has become more complex with the emergence of 
various healthcare- associated factors and regional 
differences in causative organisms.4 The inci-
dence of IE is 2–8 per 100 000 person- years and 
has been reported to be increasing.5 6 The in- hos-
pital mortality rate of IE has not shown significant 
improvement and, in fact, an increasing trend in 
mortality has been reported.7 8
To evaluate the disease burden caused by IE, it is 
important to identify the trends in its incidence and 
mortality; investigate its microbiological charac-
teristics, clinical features and treatment outcomes; 
and collect region- specific data while considering 
the regional differences in the patients’ medical 
background, microbiological distribution and resis-
tance.9 Therefore, this study aimed to evaluate the 
incidence- related and mortality- related trends, and 
the clinical and microbiological characteristics and 
treatment outcomes of IE in South Korea.
PATIENTS AND METHODS
Study population
We retrospectively analysed adult patients with IE 
admitted to Severance Hospital, a large tertiary 
care teaching hospital with 2400 beds in South 
Korea, from November 2005 to August 2017. IE 
was defined as definite or possible according to 
the modified Duke criteria, and both types were 
included in the study.10 Patients admitted for 
suspicion of IE were managed by a multidisci-
plinary team including cardiologists, cardiovascular 
surgeons and infectious disease specialists. Surgery 
was considered according to the American Heart 
Association guidelines and South Korea’s national 
guidelines.4 11 These guidelines indicate surgery for 
uncontrolled heart failure or cardiogenic shock, 
paravalvular abscess, uncontrolled infection and 
vegetation of >10 mm with systemic embolisation. 
Surgery was determined according to the agree-
ment of cardiologists and cardiovascular surgeons, 
as well as the advice of infectious disease specialists, 
if necessary. Transoesophageal echocardiography 
was performed in most patients, including those 
with negative transthoracic echocardiography find-
ings. Follow- up visits to the outpatient clinic were 
made at 1 week and at 1, 3, 6 and 12 months after 
discharge. At each visit, the patients were checked 
for evidence of heart failure and relapse of IE 
through a system review and physical examination. 
Further, if anticoagulation therapy was performed 
after valve replacement, the prothrombin time 
was determined to ensure that the proper dose 
of anticoagulation had been used. At 6 months 
after discharge, follow- up echocardiography was 
performed to evaluate valvular and ventricular 
functions. Subsequently, follow- up visits to the 
outpatient clinic were made every 6 months.
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Variables and definitions
Nosocomial infection was defined as an infection that 
occurred >48 hour after hospitalisation with no evidence of 
infection at admission. Nosocomial infection was also diag-
nosed if IE occurred within 60 days after hospital discharge 
when a high- risk procedure for bacteraemia was performed 
or when any predisposing factor for IE was present during 
hospitalisation, including dental manipulation, gastroin-
testinal manipulation, gynaecology procedures, urological 
manipulation and invasive intravascular techniques (intravas-
cular device implantation, pacemaker insertion and cardiac 
catheterisation).12–14 Among comorbidities, cardiac devices 
were defined as implantable pacemakers or defibrillators,15 
and the Charlson Comorbidity Index was used to categorise 
patients according to overall comorbidity at hospital admis-
sion.16 Among clinical symptoms and signs at diagnosis, 
neurological complications included ischaemic or haem-
orrhagic stroke, cerebral abscess and intracranial mycotic 
aneurysm, including middle cerebral artery aneurysm with 
or without cerebral haemorrhage. Complications were diag-
nosed according to clinical, CT or MRI findings.17 Periph-
eral embolic complications included pulmonary embolism, 
coronary embolism, splenic infarct or abscess, and peripheral 
limb embolisation.17 Signs of peripheral vasculitis included 
Roth spots on retinal examination, subconjunctival haem-
orrhage, Osler nodes and Janeway lesions. The Sequential 
Organ Failure Assessment (SOFA) and Acute Physiology and 
Chronic Health Evaluation (APACHE)- II scores were used to 
stratify the disease severity, and EuroSCORE II was used to 
calculate the risk of death in patients undergoing surgery.18 
Causative microorganisms were defined as those present in 
blood or tissue samples (valve and/or vegetation).
Statistical analysis
Poisson log- linear regression was used to estimate the time 
trends in IE incidence (relative risk (RR)) and mortality rate 
(incidence rate ratio (IRR)). To analyse long- term survival, we 
used mortality data obtained from the Ministry of the Inte-
rior and Safety of South Korea, which collects death informa-
tion of all Korean citizens. Comparisons were made between 
patients who died in the hospital and those who survived. 
The Mann- Whitney U- test was used to compare continuous 
variables, and χ2 or Fisher’s exact test was used for categor-
ical variables. The final logistic regression model predicting 
in- hospital mortality was constructed based on clinical 
significance among risk factors with p<0.05 in univariate 
analysis after checking for multicollinearity and interaction 
effects. Multicollinearity was defined as a variance infla-
tion factor of <5. ORs and 95% CIs were calculated from 
this analysis. The predicted performance of the final model 
was evaluated using areas under the curve (AUCs), Hosmer- 
Lemeshow test and calibration plots. To verify the efficiency 
of our model (free from overfitting, with high predictive 
performance), we compared the AUCs of our models with 
that of high- predictive performance models selected based 
on bidirectional elimination selection with Akaike’s infor-
mation criterion. The DeLong method was used to compare 
the AUCs of the models.19 Kaplan- Meier survival analysis and 
Cox regression were performed to assess long- term prognosis. 
A p value of <0.05 was considered statistically significant. 
Poisson regression analyses for trend tests were performed 
using SAS V.9.4. All other statistical analyses were performed 
using R V.3.4.4 (The R Foundation for Statistical Computing, 
Vienna, Austria).
Figure 1 Flow of patients suspected of having infective endocarditis during the study period.
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Patient and public involvement
This study was performed without patient involvement. Patients 
were not invited to comment on the study design and were not 
consulted to develop patient- relevant outcomes or to interpret 
the results. Patients were not invited to contribute to the writing 
or editing of this document for readability or accuracy.
RESULTS
Study population and characteristics
A total of 419 patients who met the inclusion criteria were 
included (figure 1). The median age was 56 years, with 275 male 
patients (65.6%). Ninety- one patients (21.7%) had nosocomial 
infection. Most patients (74%) had fever, and 129 (30.8%) had 
neurological complications. The in- hospital, 30- day and 1- year 
mortality rates were 14.6%, 8.8% and 17.4%, respectively 
(table 1).
The mitral valve was the most commonly affected valve 
(61.3%) followed by the aortic valve (43.2%), and 70 patients 
(16.7%) showed simultaneous involvement of more than two 
valves. Sixty- three patients (15.0%) developed IE related to 
prosthetic valves, and 68 patients (16.2%) had accompanying 
paravalvular complications. Inflammatory markers such as C 
reactive protein were elevated (table 2).
Incidence and mortality trends of IE
The monthly incidence rate of IE progressively increased from 
2.0 in 2005 to 3.8 in 2017. An overall significant increase over 
time was observed (RR 1.06, 95% CI 1.02 to 1.10, p=0.005). 
Table 1 Clinical characteristics and outcomes of patients with IE
Total (N=419)
Demographics
  Age (years) 56 (43–68)
  Age ≥65 years 138 (32.9)
  Male sex 275 (65.6)
  Nosocomial infection 91 (21.7)
Comorbidities
  Previous valve surgery 83 (19.8)
  Diabetes 77 (18.4)
  Antibiotic treatment within 30 days 74 (17.7)
  Cancer 54 (12.9)
  Renal disease 43 (10.3)
  Central venous catheter access 32 (7.6)
  Congestive heart failure 29 (6.9)
  Liver disease 27 (6.5)
  Haemodialysis 23 (5.5)
  Previous IE 21 (5.0)
  Cardiac device 19 (4.5)
  Immunosuppressive therapy 18 (4.3)
  Connective tissue disease 15 (3.6)
  Chemotherapy within 30 days 15 (3.6)
  Charlson Comorbidity Index 2 (0–4)
Clinical symptoms and signs
  Fever 310 (74.0)
  Sepsis, including septic shock 294 (70.2)
  Left ventricular dysfunction 141 (33.7)
  Neurological complications 129 (30.8)
  Peripheral embolic complications 35 (8.4)
  Signs of peripheral vasculitis 9 (2.1)
Outcomes
  Acute renal failure 62 (14.8)
  New- onset heart failure 58 (13.8)
  New- onset conduction abnormality 32 (7.6)
  In- hospital mortality 61 (14.6)
  30- day mortality 37 (8.8)
  1- year mortality 73 (17.4)
Data are presented as median (IQR) or number (%) of patients.
IE, infective endocarditis.




  Mitral valve 257 (61.3)
  Aortic valve 181 (43.2)
  Tricuspid valve 34 (8.1)
  Pulmonary valve 16 (3.8)
  Multiple valves 70 (16.7)
  Prosthetic valve 63 (15.0)
  Paravalvular complications 68 (16.2)
  Associated ventricular septal defect 11 (2.7)
  Vegetation size (cm) 1.1 (0.7–1.6)
Preoperative laboratory findings (normal range)
  White blood cell count, ×103 (4.0–10.8) 9.54 (6.92–12.95)
  Segmented neutrophil (%) (39.0–74.0) 79.4 (70.3–86.5)
  Platelet count, 103/μL (150.0–400.0) 202 (133–280)
  Erythrocyte sedimentation rate (mm/hour) (0.0–15.0) 61 (36–83)
  C reactive protein (mg/L) (0.0–8.0) 46.8 (10.3–103.0)
  Procalcitonin, ng/mL (0.00–0.50) 0.35 (0.16–1.13)
Severity scales
  SOFA score 1 (1–3)
  APACHE- II score 6 (4–9)
Data are presented as median (IQR) or number (%) of patients. Normal range refers to the 
hospital criteria.
APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure 
assessment.
Figure 2 Trends in the incidence and mortality rate of infective 
endocarditis according to calendar year in Poisson log- linear regression. 
Trends are depicted as green dashed lines.
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The proportion of patients admitted with IE among all inpa-
tients of the cardiovascular surgery division of our hospital also 
exhibited an increasing trend over time (IRR 1.03, 95% CI 1.01 
to 1.06, p=0.042). The mortality rate showed a statistically 
significant, gradually declining trend (IRR 0.93, 95% CI 0.88 to 
0.99, p=0.020) (figure 2).
Changes in causative microorganisms with calendar year
Among the 419 patients, causative microorganisms of IE were 
identified in 309 (73.7%). Streptococcus species were the most 
common species identified (35.1%), followed by Staphylococcus 
aureus (15.8%), Enterococcus species (8.6%) and coagulase- 
negative staphylococci (7.6%) (online supplemental table S1). 
Causative microorganisms were identified in 61 of 91 patients 
with nosocomial infection. Among these cases, S. aureus was the 
most commonly identified microorganism (19 cases), followed 
by Streptococcus species (14 cases). Streptococcus species were 
consistently identified most frequently throughout the study 
period, and no specific trend was identified for other isolates 
(figure 3).
Results of patients who underwent surgery
Among the 419 patients, 273 (65.2%) underwent surgery 
for IE. No difference was noted in the proportion of patients 
undergoing surgery over time (IRR 1.01, 95% CI 0.97 to 1.05, 
p=0.688) (online supplemental figure S1). Patients who under-
went surgery had in- hospital, 30- day and 1- year mortality 
rates of 7.3%, 3.7% and 7.7%, respectively (table 3). Kaplan- 
Meier curves showed that patients who underwent surgery 
had a significantly higher long- term survival rate than those 
who received medical treatment only (p<0.001, log- rank 
test) (figure 4). The effects of surgery on long- term prognosis 
were robust after adjustment for potential confounders with 
Cox regression (HR 0.20, 95% CI 0.11 to 0.34, p<0.001). 
The mortality rate tended to be lower after 2012 than before, 
although the difference was not significant (5.1% vs 9.5%, 
p=0.169). In contrast, the median time between diagnosis and 
surgery was significantly shorter after 2012. Thus, the number 
of patients who underwent surgery within 7 days after diagnosis 
was significantly higher after 2012 than before (60.3% vs 
29.2%, p<0.001) (table 4). Among the 101 patients who under-
went surgery to prevent embolism, systemic embolic events (five 
in the middle cerebral artery, three in the spleen and one in 
the kidney) occurred significantly less frequently in the early 
surgery group than in the late surgery group during hospitalisa-
tion (2.1%, 1/48, vs 15.1%, 8/53; p=0.033).
Figure 3 Distribution of microorganisms causing infective 
endocarditis according to calendar year. CNS, coagulase- negative 
staphylococci; GNB, Gram- negative bacillus; MRSA, methicillin- resistant 
Staphylococcus aureus; MSSA, methicillin- susceptible Staphylococcus 
aureus.
Table 3 Indications, timing and outcomes in 273 patients who 
underwent surgery for infective endocarditis
Total (N=273)
Surgical indications
  Congestive heart failure 217 (79.5)
  Prevention of embolism 101 (37.0)
  Paravalvular complications 58 (21.2)
  Uncontrolled infections 19 (7.0)
  Pacemaker infections 7 (2.6)
Valve locations
  Mitral valve 174 (63.7)
  Aortic valve 131 (48)
  Tricuspid valve 17 (6.2)
  Pulmonary valve 10 (3.7)
  Multiple valves 56 (20.5)
Timing of surgery
  Surgery within 24 hours 12 (4.4)
  Surgery within 2–7 days 110 (40.3)
  Surgery at >7 days 151 (55.3)
EuroSCORE II (%) 6.2 (4.7–9.3)
Replaced valve
  Mechanical valve 184 (67.4)
  Bioprosthetic valve 68 (24.9)
  Bentall operation 5 (1.8)
  Homograft 3 (1.1)
  Valve repair only 18 (6.6)
Outcomes
  New- onset heart failure 32 (11.7)
  Acute renal failure 29 (10.6)
  New- onset conduction abnormality 27 (9.9)
  In- hospital mortality 20 (7.3)
  30- day mortality 10 (3.7)
  1- year mortality 21 (7.7)
Data are presented as median (IQR) or number (%) of patients.
Figure 4 Kaplan- Meier curves of the long- term survival rates of 
patients with infective endocarditis who underwent surgery versus 
those who underwent medical treatment only.
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Risk factors for in-hospital mortality
Sixty- one of the 419 patients (14.6%) died during the hospital 
stay. On univariate analysis, various variables were identified as 
risk factors for mortality (online supplemental table S2). After 
checking for multicollinearity, several factors were selected as 
variables for multivariable logistic regression analysis based on 
clinical significance. To verify the predictive performance of the 
selected logistic regression model, receiver operating character-
istics curves were generated (AUC=0.83). Using the DeLong 
method, we found the model to be non- inferior to other possible 
models selected with bidirectional elimination selection using 
Akaike’s information criterion. The model was also identified 
as appropriate (p=0.118) with the Hosmer- Lemeshow test. 
Multivariable logistic regression analysis indicated that aortic 
valve endocarditis (OR 3.18, 95% CI 1.63 to 6.19, p=0.001), 
S. aureus infection (OR 2.32, 95% CI 1.11 to 4.85, p=0.026), 
neurological complications (OR 1.98, 95% CI 1.07 to 3.69, 
p=0.031), high SOFA score (OR 1.22, 95% CI 1.03 to 1.45, 
p=0.023) and high Charlson Comorbidity Index (OR 1.11, 95% 
CI 1.02 to 1.22, p=0.019) were independent risk factors for 
in- hospital mortality from IE. The protective effect of surgery 
against in- hospital mortality remained robust (OR 0.25, 95% 
CI 0.13 to 0.50, p<0.001) after adjusting for other variables 
(online supplemental table S3).
DISCUSSION
Studies have identified a stable incidence of IE, although most 
have reported an increasing trend over time.5 7 We found an 
increasing trend during each calendar year of the study period. 
The increasing trend was also identified when hospital size was 
considered according to inpatient ratio. This is likely related 
to an increase in the sizes of high- risk populations comprising 
individuals with older age, diabetes and haemodialysis therapy.20 
Actually, in this study, the median patient age tended to increase 
over time, although not statistically significant (IRR 1.01, 95% 
CI 0.99 to 1.03, p=0.570) (online supplemental figure S2). 
Moreover, the number of invasive procedures, including spinal 
surgery, which could lead to transient bacteraemia, has markedly 
increased over time.21
Streptococcus species have continued to be the major caus-
ative organisms of IE. The frequency of isolation of these species 
did not decrease, but rather increased, over the calendar years 
studied. Because Streptococcus species are the major microorgan-
isms contributing to IE development, which is preventable with 
antibiotic prophylaxis, it is possible that antibiotic prophylaxis 
for IE was not effectively performed during the study period. In 
fact, according to South Korea’s national guidelines, antibiotic 
prophylaxis for IE was performed in patients with the highest risk 
of an adverse outcome of IE.11 Antibiotic prophylaxis was recom-
mended in patients with a high risk of bacteraemia during dental 
procedures, which may involve the manipulation of the gingival 
or periapical region of teeth or perforation of the oral mucosa 
(including scaling and root canal procedures). However, Ki et al 
reported that the prescription rate of prophylactic antibiotics for 
IE was only 14.1%, which may explain the sustained develop-
ment of IE caused by Streptococcus species.22 The high incidence 
of IE caused by Streptococcus may explain why patients with IE in 
South Korea are younger than those in Western countries.
A study from the UK showed an increase in the incidence of IE 
with a decrease in prophylactic antibiotic use, after the National 
Institute for Health and Care Excellence (NICE) guidelines 
were modified in 2008.1 However, in South Korea, the national 
guidelines for IE were revised in 2011 and did not include all 
of the NICE guidelines.11 Further, the preguideline revision era 
was shorter than the postguideline revision era during our study 
period, and the prescription rate of prophylactic antibiotics for 
IE was low. Therefore, we did not observe any significant change 
in the incidence and microbiological profile of IE between the 
two periods.
The overall in- hospital mortality rate of patients with IE was 
14.6%, which is lower than that in a study performed in Japan 
(with a similar racial background to South Korea).23 This may 
be because of the younger patient age and the lower propor-
tion of infections caused by S. aureus in our study. Meanwhile, 
the mortality rate declined over each calendar year. To under-
stand the decline in the in- hospital mortality rate over the 
calendar years, factors affecting mortality need to be considered. 
Although the number of resistant bacterial strains has increased, 
the proportion of resistant strains, such as methicillin- resistant 
S. aureus, did not significantly increase during the study period. 
Streptococcus species remained the most frequently identified 
microorganisms, which might have contributed to the favour-
able outcomes. Moreover, early surgery has been reported to 
improve the prognosis of IE.24 Thus, in recent years, surgery 
for IE has been performed earlier, which likely facilitated the 
gradual decline in the in- hospital mortality rate of IE in South 
Korea.
In this study, there were patients (n=29) who met the surgical 
criteria but did not undergo surgery because of multiorgan 
failure and comorbidities. Therefore, although surgical interven-
tion reduces the in- hospital mortality rate of IE, there is a poten-
tial for bias because the severity of IE in patients who underwent 
surgery might be less than that in patients who received medical 
treatment only. To clarify this, we used the Charlson Comor-
bidity Index and SOFA score as variables in multivariable logistic 
regression analysis to adjust for the patients’ medical background 
and disease severity. We also assessed the interaction effects 
between surgical intervention and the Charlson Comorbidity 
Index and SOFA score. No interaction between these factors 
was identified. This result is consistent with previous reports 
that surgery in IE is associated with a good prognosis.25 26 Our 
findings on the impact of early surgery to prevent embolism are 
consistent with those of previous studies and support the guide-
line recommendations.4 27
Table 4 Changes in the timing of surgery according to calendar year
Total 2005–2012 2013–2017 P value
No. of patients who underwent surgery 273 (100.0) 137 (100.0) 136 (100.0)
Surgery within 7 days 122 (44.7) 40 (29.2) 82 (60.3) <0.001*
Days from diagnosis to surgery 8.0 (4.0–17.0) 11.0 (5.0–22.5) 6.0 (4.0–11.0) <0.001†
In- hospital mortality 20 (7.3) 13 (9.5) 7 (5.1) 0.169*
Data are presented as a median (IQR) or number (%) of patients.
*χ2 test.
†Mann- Whitney U- test.
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To identify factors affecting the in- hospital mortality rate of 
IE, we selected variables for multivariable logistic regression 
analysis (based on clinical significance) from among the signif-
icant variables in univariate analyses. The logistic regression 
model including these variables was compared with two logistic 
regression models selected using bidirectional elimination selec-
tion to verify the predictive performance. Our model not only 
was non- inferior to the other two models in predictive perfor-
mance but also was free of problems of overfitting. Therefore, 
we concluded that the model is appropriate for predicting 
in- hospital mortality from IE and that the selected variables 
in the model are significant. This rigorous statistical process 
strengthens our conclusions.
Patients with aortic valve endocarditis had a poor prognosis. 
Conversely, Kaartama et al28 reported that patients with aortic 
valve endocarditis had better short- term and long- term survival 
than those with mitral valve endocarditis. In their study, the mean 
patient age and the frequency of S. aureus infection were higher 
in patients with mitral valve endocarditis than in those with 
aortic valve endocarditis. Further, surgery was delayed in patients 
with mitral valve endocarditis. However, in our study, patients 
with aortic valve endocarditis were significantly older than those 
without (mean age 58.4 vs 53.6 years, p=0.009). Moreover, in 
patients with aortic valve endocarditis, the median SOFA (2.0 
vs 1.0, p<0.001) and APACHE- II (7.0 vs 6.0, p=0.014) scores 
were significantly higher than in those without aortic valve endo-
carditis. Additionally, there was no difference in the frequency of 
S. aureus infection (14.7% vs 16.7%, p=0.640) or in the propor-
tions of patients who underwent surgery within 7 days after the 
IE diagnosis (63.8% vs 61.5%, p=0.682) between patients with 
and without aortic valve endocarditis. This suggests that aortic 
valve endocarditis may not confer a good prognosis and that 
clinical features should be considered in assessing the prognosis 
of IE.
Because many variables affect the in- hospital mortality rate 
of patients with IE, we used the Charlson Comorbidity Index to 
represent comorbidities, including age, and the SOFA score to 
indicate disease severity. Both variables were identified as inde-
pendent risk factors for in- hospital mortality in patients with 
IE. The other independent risk factors for in- hospital mortality 
in patients with IE were S. aureus infection and neurolog-
ical complications. These findings are consistent with those of 
previous studies.29 30
This study had some limitations. First, it was a non- randomised 
retrospective study and certain clinical variables might have 
been missed. Although we used rigorous statistical analysis to 
adjust for host- related factors and disease severity, unmeasured 
confounders could have affected the outcomes. Second, because 
there are very few intravenous drug users in South Korea, the 
effect of intravenous drug use on IE could not be evaluated. Third, 
this was performed at a single centre, which limits the extrapo-
lation of our results to the overall trends of IE in South Korea. 
Moreover, the incidence, microbiological profile and severity of 
disease may have been biassed, as this study was performed in a 
single country. However, our results are still meaningful because 
data on IE trends in Asia are currently lacking. Further nation-
wide population- based studies and multinational cohort studies 
are needed to validate our findings.
In conclusion, the incidence of IE has increased over time and 
the mortality rate has slightly declined but remains high. Strep-
tococcus species were the most common causative organisms of 
IE throughout the study period. Aortic valve endocarditis, IE 
caused by S. aureus, high SOFA score, high Charlson Comor-
bidity Index and presence of neurological complications were 
independent risk factors for in- hospital mortality in patients with 
IE, whereas surgical intervention for IE was associated with an 
improved prognosis. Further nationwide studies on the trends, 
causative organisms and risk factors of IE are needed.
Key messages
What is already known on this subject?
 ► Studies have reported that the incidence of infective 
endocarditis (IE) is increasing, and its mortality rate has not 
shown significant improvement. Although many variables 
were reported to be related to in- hospital mortality in 
patients with IE, the study results differed according to 
the statistical method. In particular, the effects of surgical 
treatment on long- term prognosis were not conclusive.
What might this study add?
 ► This study shows that the incidence of IE is increasing and 
that, although the in- hospital mortality rate has slightly 
decreased, it remains high in South Korea. Data about the 
causative microorganisms of IE and factors affecting in- 
hospital mortality, determined using rigorous statistical 
methods, are also provided. Finally, this study reveals that 
surgical intervention has a protective effect with respect to 
both in- hospital mortality and long- term mortality.
How might this impact on clinical practice?
 ► Given the increasing incidence and high mortality rate, the 
disease burden of IE is significant. The fact that Streptococcus 
species are still the main causative microorganisms means 
that antibiotic prophylaxis for IE should be improved. Because 
the protective effect of surgical intervention against in- 
hospital mortality and long- term mortality was identified, a 
more active approach to surgical treatment is needed.
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